As of November 2024 BioMarin Pharmaceutical has a market cap of C$17.70 Billion. This makes BioMarin Pharmaceutical the world's 1395th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 2nd, 2024 the market cap of BioMarin Pharmaceutical was reported to be: